Today: 29 April 2026
Browse Category

LSE:BLND 19 November 2025 - 21 April 2026

FTSE 100 Today: British Land Rally Masks AB Foods Slide as UK Stocks Edge Up

FTSE 100 Today: British Land Rally Masks AB Foods Slide as UK Stocks Edge Up

The FTSE 100 rose 0.12% to 10,622.06 in delayed London trade Tuesday, while the FTSE 250 gained 0.39%. British Land climbed after boosting earnings guidance and signing Anthropic as a tenant. Associated British Foods fell on plans to split Primark from its food units and a profit warning. Crest Nicholson plunged nearly a third after cutting its outlook and warning on home completions.
British Land’s leasing jump fuels UK dividend hunt as Legal & General’s 8% yield grabs attention

British Land’s leasing jump fuels UK dividend hunt as Legal & General’s 8% yield grabs attention

British Land signed 882,000 sq ft of leases in the third quarter, 8.5% above estimated rental value, and kept its earnings forecast. The company reported 1.8 million sq ft under offer and said retail park occupancy stands at 99%. UK inflation rose in December, but analysts expect the Bank of England to cut rates three times this year. Investors remain cautious about dividend risks despite British Land’s 5.5% yield.
UK Stock Market Opening Preview for 4 December 2025: FTSE 100 Outlook, Key Data and Stocks to Watch

UK Stock Market Opening Preview for 4 December 2025: FTSE 100 Outlook, Key Data and Stocks to Watch

The FTSE 100 closed down 0.1% on December 3, with miners rising on record copper prices and banks falling after the FCA said it will resume handling motor-finance mis-selling complaints in May 2026. WPP will exit the FTSE 100, replaced by British Land. Sainsbury dropped over 4% after Qatar’s wealth fund moved to cut its stake. UK services PMI slipped to 51.3 in November, signaling slower growth.

Stock Market Today

  • Ceres Power Surges Past Rolls-Royce, Nvidia, BP in FTSE 250 Rally
    April 29, 2026, 9:27 AM EDT. Ceres Power (LSE:CWR) leads the FTSE 250 stock gains in 2026 with a staggering 176% rise year-to-date, far outpacing Rolls-Royce, Nvidia and BP. The clean energy tech firm, specializing in licensing advanced solid oxide fuel cell and hydrogen technology, posted a remarkable 933% gain over the last year. Despite declining revenues - £32.6 million in 2025 down from £51.9 million the previous year - and no expected profits in 2026 or 2027, investor enthusiasm is fueled by the AI-driven data center boom. Its recent collaboration with Centrica aims to deploy efficient on-site power solutions swiftly for AI hubs and logistics centers. This positions Ceres as a crucial 'picks and shovels' provider amid the AI energy surge. However, over five years, the stock remains down 55%, prompting debate on its current valuation.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop